Compound Summary
Compound Name: | Tetrahydrocurcumin |
Compound CID: | 124072 |
Synonyms: | Tetrahydrocurcumin 36062-04-1 1,7-bis(4-hydroxy-3-methoxyphenyl)heptane-3,5-dione Sabiwhite Tetrahydrodiferuloylmethane More... |
Iupac Name: | 1,7-bis(4-hydroxy-3-methoxyphenyl)heptane-3,5-dione |
InChI: | InChI=1S/C21H24O6/c1-26-20-11-14(5-9-18(20)24)3-7-16(22)13-17(23)8-4-15-6-10-19(25)21(12-15)27-2/h5-6,9-12,24-25H,3-4,7-8,13H2,1-2H3 |
InChIKey: | LBTVHXHERHESKG-UHFFFAOYSA-N |
Canonical Smiles: | COC1=C(C=CC(=C1)CCC(=O)CC(=O)CCC2=CC(=C(C=C2)O)OC)O |
Isomeric Smiles: | COC1=C(C=CC(=C1)CCC(=O)CC(=O)CCC2=CC(=C(C=C2)O)OC)O |
Molecular Weight: | 372.4 |
Molecular Formula: | C21H24O6 |
Molecular Weight: | 372.4 |
Molecular Formula: | C21H24O6 |
Hydrogen Bond Donor Count: | 2 |
Hydrogen Bond Acceptor Count: | 6 |
Rotatable Bond Count: | 10 |
Heavy Atom Count: | 27 |
Complexity: | 437 |
Tetrahydrocurcumin | Tetrahydrocurcumin |
---|---|
Tetrahydrocurcumin |
36062-04-1 |
1,7-bis(4-hydroxy-3-methoxyphenyl)heptane-3,5-dione |
Sabiwhite |
Tetrahydrodiferuloylmethane |
1,7-Bis(4-hydroxy-3-methoxyphenyl)-3,5-heptanedione |
3,5-Heptanedione, 1,7-bis(4-hydroxy-3-methoxyphenyl)- |
UNII-00U0645U03 |
CHEMBL318743 |
CHEBI:67263 |
MFCD04152347 |
NSC687845 |
00U0645U03 |
NSC 687845 |
Tetrahydrocucumin |
HZIV 81-2 |
3,5-Heptamedopme. 1,7-bis(hydroxy-3methoxyphenyl)heptane |
EC 609-201-3 |
THC (Tetra Hydro Curcumin) |
SCHEMBL284877 |
DTXSID30865801 |
BCP18621 |
HY-N0893 |
ZINC4649679 |
BDBM50059985 |
s3917 |
Tetrahydrocurcumin, >=96% (HPLC) |
AKOS015999950 |
Tetrahydrocurcumin, analytical standard |
CCG-268326 |
CS-3739 |
NSC-687845 |
VN10058 |
AC-24240 |
AS-13957 |
SY047647 |
AB0024474 |
FT-0674986 |
W5754 |
062T041 |
J-504043 |
Q27135730 |
1,7-bis(4-hydroxy-3-methoxy-phenyl)heptane-3,5-dione |
1,7-Bis-(4-hydroxy-3-methoxy-phenyl)-heptane-3,5-dione |
Aids110028;Aids-110028;Aids 110028 pound>>Tetrahydrodiferuloylmethane pound>>HZIV 81-2 |
Species | Dose | Unit | Control(Avg days) | Treatment(Avg days) | Avg/Med Lifespan Change(%) | Control(Max days) | Treatment(Max days) | Max Lifespan Change(%) | Significant | Strain | Gender | PubMed | Avg/Med Lifespan Change tab |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mus musculus | 0.200000000000000 | % | 806.100000000000000 | 828.700000000000000 | 0.030000000000000 | 963.000000000000000 | 1024.000000000000000 | 0.060000000000000 | NS | C57BL/6J | MALES | 17516143 | Inactive |
Mus musculus | 0.002000000000000 | % | 797.000000000000000 | 882.000000000000000 | 0.110000000000000 | S | MALES | 15247057 | Active | ||||
Mus musculus | 0.200000000000000 | % | 797.600000000000000 | 882.700000000000000 | 0.110000000000000 | 1041.000000000000000 | 1108.000000000000000 | 0.060000000000000 | S | C57BL/6J | MALES | 17516143 | Active |
Species | Avg/Med Lifespan Change(%) | Max Lifespan Change(%) | Count Reference | Count Data point |
---|---|---|---|---|
Mus musculus | 0.110000000000000 | 0.060000000000000 | 2 | 3 |